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Permeation of skin with (C60) fullerene
dispersions
Dispersions in transcutol/isopropyl myristate make C60 fullerene molecules suitable
for transdermal delivery. We found that C60 can successfully permeate the skin using
pig skin in Franz diffusion cells. Molecular dynamics simulations and transmission
electronmicroscopy confirmed these observations. Basic cosmetic formulationswith
transcutol/isopropyl myristate without harsh organic solvents show a high potential
for delivery of C60 for biopharmaceutical and cosmetics applications.
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1 Introduction
Fullerenes are hydrophobic molecules composed of carbon
atoms arranged in a spherical geometry with a hollow inte-
rior. In fullerenes, carbon atoms are typically interconnected by
alternating length bonds. Thus, presents sp2 carbon atoms hy-
bridization arranged in hexagons and pentagons [1]. Fullerenes
have attracted much attention of researchers from the discov-
ery of their potential as a potent antioxidant [2–4]. Fullerenes
are capable of scavenging free radicals including reactive oxygen
and nitrogen species [5, 6]. These reactive species are generated
in cells, and their presence induces cellular instability that leads
to damage and ultimately cell death. Antioxidants are molecules
able to perform the elimination or neutralization of free radical
electrons. The benefits of antioxidants have been extensively in-
vestigated, particularly in general heath (e.g. extending the lifes-
pan) or in skin aging (delaying the normal aging process) [7, 8].
Fullerene C60 can exhibit antioxidant functionality as it read-
ily reacts with many free radicals deactivating them effectively.
The discovery of this buckminsterfullerene, a stable and very
symmetrical structure (carbon cluster) with 60 atoms, opened
up an innovative way to treat a wide range of pathologies and
diseases [9]. This include, radiation exposure [10], degenera-
tive process related with skin aging [11], degenerative diseases
(Parkinson’s,Alzheimer’s,multiple sclerosis) [12,13], osteoporo-
sis [14], and, in general, inflammatory processes [15]. However,
potential applications ranging from cosmetic/pharmaceutical to
medical treatments have been impaired due to the fact that C60
is insoluble in water and polar solvents. Several solvents have
been explored to solubilize fullerene C60 [16–19]. The toxicity
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of C60 fullerene is dependent of its structure, composition, and
morphology [20]. The generalization aboutC60 fullerene toxicity
it is ambiguous because it is dependent of several factors, such
as, dose and time-dependent, functional groups in the case of
functionalization, method of administration among others [21].
Therefore, future toxicological studies will be crucial for safety
and effective methodologies.
To overcome the water solubility problem of C60 differ-
ent biocompatible approaches is required. Fullerene derivatives
have been developed for instance by covalent functionaliza-
tion with hydrophilic chemical groups or by the encapsula-
tion into supramolecular complexes such as cyclodextrin or
polyvinylpyrrolidone [22, 23]. Further research demonstrated
the solubility of fullerene C60 in fatty acids [24, 25] that al-
lowed the possibility to use fatty acid esters of glycerol or others,
for the delivery of fullerene and fullerene derivatives in living
organisms [26]. Based on this, we developed herein dispersions
of fullerene C60 in fatty acids suitable for transdermal applica-
tion. As far as we know there is no cosmetic/pharmaceutical
formulation available using fullerene C60 in isopropyl myristate
and/or transcutol. These dispersions make fullerene C60 suitable
to be delivered transdermally by direct application in the skin
without harsh organic solvents or any chemical modification or
encapsulation process.
2 Materials and methods
2.1 Materials
Fullerene C60 (purity: 99.5%) and isopropyl myristate (IPM)
were purchased from Sigma-Aldrich (Spain). Transcutol (TRC)
(diethylene glycol monoethyl ether) was kindly provided from
Gattefosse´ Corporation (France). The skin permeation study
was performed using pig skin that was kindly supplied by a
slaughterhouse (Matadouro Central de Entre Douro e Minho,
732 C© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.els-journal.com Eng. Life Sci. 2017, 17, 732–738
Figure 1. Visual illustration of fullerene C60 dis-
persions (0.8 mg/mL) in IPM (left), in IPM with
Transcutol (20% TRC) (center) and in water
(right).
Portugal). All reagents were used as received without further
purification.
2.2 Preparation method of fullerene C60 dispersions
The preparation of the fullerene C60 dispersions were as follows.
The solid fullerene C60 was dispersed in water, in IPM and in
IPM with 20% transcutol to a final concentration of 0.8 mg/mL
of C60 for all solutions. The dispersions were vigorously stirred
for 3 h at a room temperature with a magnetic stirrer.
2.3 In vitro permeation studies
The permeation profile was undertaken on a Franz diffusion cell
(V-Series Franz Cells, PermeGear, USA). This apparatus consists
of three cells, each one with a donor and receptor compartment.
The pig skin specimen was mounted between the donor and
receptor compartments, and 300 μL of the dispersion solution
of C60 was placed on the top of the skin surface in the donor
compartment. The receptor compartmentwasfilledwith 5mLof
0.01Mphosphate buffered saline (pH7.4) that was continuously
stirred. The receptor liquid was maintained at 37°C using a
circulating water bath for 24 h. A control sample was run in
parallel with each assay.
The quantification of C60 in the receptor and donor compart-
mentswasdeterminedby a simple liquid–liquid extraction (LLE)
method. The experiments were carried out by mixing equal vol-
umes of aqueous and organic (toluene) phases (5 mL). After
extraction from the sample solution fullerene C60 was quantified
by UV-vis spectroscopy.
2.4 Transmission electron spectroscopy
To visualize the C60 dispersions morphology into the skin,
the samples were fixed with 2.5% glutaraldehyde and 2%
paraformaldehyde in cacodylate buffer 0.1 M (pH 7.4). After
post fixed in 2% osmium tetroxide in the same buffer, the sam-
ples were dehydrated with ethanol, carefully cut off, and em-
bedded in Epon resin. Ultrathin sections (40–60 nm thickness)
were prepared on a RMC Ultramicrotome (PowerTome, USA)
using diamond knives (DDK, Wilmington, DE, USA). The sec-
tions were mounted on 200 mesh copper or nickel grids, stained
with uranyl acetate and lead citrate for 5 min each, and exam-
ined under a JEOL JEM 1400 TEM (Tokyo, Japan). Images were
digitally recorded using a CCD digital camera Orious 1100 W
Tokyo, Japan.
2.5 Molecular dynamics simulations
The simulations were performedwithGROMACS 4.6 [27] pack-
age using Martini force field [28]. The system size was chosen
according to the minimum image convention taking into ac-
count a cut-off of 1.2 nm. The bonds lengths were constrained
with LINCS [29]. Nonbonded interactions were calculated using
a twin-range method, with short and long range cut-offs of 0.9
and 1.2 nm, respectively. Neighbor searching was carried out up
to 1.2 nm and updated every ten steps. A time step of integration
of 20 fs was used. A reaction field correction for the electro-
static interactions was applied using a dielectric constant of 15.
Pressure control was implemented using the Berendsen baro-
stat [30], with a reference pressure of 1 bar, 3.0 ps of relaxation
time and isothermal compressibility of 3.0 × 10−5 bar−1. Tem-
perature control was set using the Berendsen thermostat [30] at
300 K. Each component of the system was included in separated
heat bath, with temperatures coupling constants of 0.30 ps. The
lipid membrane was built using the same approach described
in our previous work [31]. The membranes are composed by
ceramid-2, lignoceric acid, cholesterol, and cholesterol sulphate.
The stratum corneum is composed by repeating units of double
bilayers of this lipids. The separation between bilayers is around
5 A˚, and the separation between the repeating double bilayers is
typically 25 A˚.
In all cases, the fullerenemolecules were positioned randomly
inwater at the beginning of the simulations. The total simulation
time, after the initial 20 ns of equilibration, was 1 μs for each
simulation. For the simulations with several fullerene molecules
the same conditions were applied. The objective is to demon-
strate the behavior of the system under different concentrations
of fullerenemolecules. The number of added fullerenemolecules
has no direct correlation with experimental concentration.
In addition, a pulling simulation was performed for the
fullerene molecule crossing the membrane, in order to calcu-
late the potential of mean force of the process. For this, after an
equilibration step of 20 ns, a 20 ns simulation with a pull rate of
0.3 nm/ns and a pull force constant of 1000 kJ/(mol nm2) was
run.
3 Results and discussion
The method used to prepare C60 dispersions was throughout
a single phase mixture. Fullerene C60 at a concentration of
0.8 mg/mL was mixed in three different solutions: in IPM, in
IPM with 20% TRC and in water. The samples were stirred un-
til forming a uniform solution. Fullerene C60 dispersed in IPM
and in IPM with TRC, but did not disperse in water as pristine
fullerenes are insoluble inwater.Dispersions showed a character-
istic brown color (Fig. 1). After preparation of the dispersions,
UV-vis spectroscopy was used to measure the presence of the
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Figure 2. UV-vis spectrum of fullerene C60 dispersions prepared
with a solution of toluene, with IPM and with IPM with 20% TRC.
fullerenes C60 (Fig. 2). All dispersions show a characteristic ab-
sorption peak located between 330–340 nm due to the presence
of C60 molecules [32]. The UV-vis spectrum confirmed the vi-
sual observation of the samples, the (darker) solution of IPM
with TRC presented larger quantities of the C60. Fullerene C60 in
toluene was used as control sample for the absorption spectrum.
The poor solubility of fullerene C60 in aqueous solutions
has captured the attention of researchers. Basically this prob-
lem has been overtaken by functionalization [33, 34]. A variety
of investigations of well-characterized compounds for potential
applications in biomedicine have been conducted in biopharma-
ceuticals and cosmetics [2, 35–37]. An alternative, simpler, way
for fullerene C60 application has also been explored using fatty
acid esters of glycerol as biocompatible solvents. The solubility of
fullereneC60 can be effective using vegetable oils [24,38,39]. This
prompted us to study C60 dispersions with suitable oils for cos-
metics/pharma applications: the isopropyl myristate associated
with transcutol. IPM presents good spreading properties and is
easily absorbed into the skin constituting an excellent substitute
for natural oils [40]. The presence of transcutol in the solution
of IPM allowed a better dispersion of the fullerene C60 due to its
powerful solubilization properties. In addition, the nontoxicity
and biocompatibility of transcutol with the skin also makes it an
attractive penetration enhancer [41, 42].
The quantitative and qualitative permeation of the fullerene
C60 was investigated through in vitro transdermal perfusion us-
ing Franz diffusion cells. Porcine skin was used because presents
thickness and absorption rates similar to those of human skin
[43–51]. The pig skin was removed from the Franz diffusion cell
after the incubation period.
Then, the liquid in donor and receptor compartments was
analyzed to measure the fullerene C60 concentration in each
compartment. For that, a simple LLEmethod was used. The cal-
ibration curvewas previously obtained by fullereneC60 solutions
dissolved in toluene. Thus, fullerene C60 that crossed the entire
length of the skin until reach the receptor compartment (in the
aqueous phase)was extracted to toluene by LLE (using equal vol-
umes: 5 mL). After addition of toluene two immiscible phases
were formed. After vigorous agitation the fullerene C60 was sep-
arated. After separation, the phase containing the fullerene C60
was removed and quantified by its UV-vis absorbance at 340 nm.
About 10%of fullerene C60 remained on top (donor) and 14%of
fullerene C60 crossed the skin until the receptor compartment.
The difference between the detected amount of fullerene C60
in donor and in receptor compartment was 76% meaning that
fullerene C60 was mainly retained into the skin.
The qualitative permeation of the fullerene C60 through the
intact skin was investigated by transmission electronmicroscopy
(TEM) analysis. The integrity of the skin was monitored and
maintained intact to ensure a valid permeation profile of the
fullerene C60 through the pig skin. Prior to the TEM analysis
the skin samples were washed to remove any compounds of the
formulation. The samples were frozen at –80°C for later section-
ing and mounting in copper grids for TEM visualization. The
dispersed fullerene C60 was able to cross the intact skin from
stratum corneum until dermis layer, the inner layer of the skin.
The localization and permeation extend of fullerene C60 is de-
picted by TEM analysis in Fig. 3 that clearly show the presence
of C60 aggregates in the skin sample. This is consistent with
the results attained by in vitro permeation profile (quantita-
tive assessment) as well as by molecular dynamics simulations
(Fig. 4).
After the experimental evidence on the ability of fullerene
C60 to cross the skin, molecular dynamics simulations were per-
formed to clarify the mechanism leading to the penetration of
the fullerene molecules into the skin. Drug molecules in contact
with the skin surface can penetrate by three potential pathways:
through the sweat ducts, via the hair follicles and sebaceous
glands (collectively called the shunt or appendageal route), or
directly across the stratum corneum [52]. However, it is generally
accepted that as the appendages comprise a fractional area for
permeation of approximately 0.1%, the major contribution to
steady-state flux of most drugs come from the stratum corneum.
Our model of the stratum corneum is a model of the lipidic
membrane. To penetrate through the skin, the molecules have
to cross the lipidic membrane, as this membrane occupies the
spaces between the corneocytes. Our molecular models show
that the fullerene C60 has the ability to penetrate the membrane
unaided, Fig. 4. It is also possible to observe that for higher con-
centrations (Fig. 4, B2), the fullerene molecules form aggregates
inside themembrane, which is in linewith ourTEMexperiments
and previous computer simulations in similar systems [53].
Fullerene aggregates are not present at lower concentrations
(Fig. 4, A2).
Full permeation of the fullerene C60 throughout the mem-
brane was not observed in our MD (1 μs) simulations. Either
the process is kinetically unlikely, or the symmetry conditions
in this type of simulations, with periodic boundary conditions
lack the driving force necessary to observe the complete perme-
ation as the top layer of the membrane shares the same chemical
potential with the bottom layer.
In order to study the complete permeation of C60, the changes
in the free energy for a fullerene C60 molecule traversing the
membrane were computed. After a pulling simulation, repre-
sented in Fig. 5, the potential of the mean force across the tra-
jectory was determined through umbrella sampling. On Fig. 6
is depicted the variation of potential of mean force calculated
across the trajectory of the pulling simulation of fullerene. It
is not easy for fullerene molecules to cross the water layers in-
side the lipid membrane, and the charged head groups of the
lipids, in contact with water could have a major influence in
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Figure 3. Detection of the fullerene C60
into the dermis layer of the pig skin.
TEM images of (A) a dispersion solu-
tion of fullerene C60; the scale bar rep-
resents 500 nm; (B) pig skin in absence
of fullerene C60; the scale bar repre-
sents 200 nm; (C) and (D) pig skin with
fullerene C60; the scale bar represents
100 nm.
Figure 4. Molecular dynamics
snapshots showing fullerene
spheres penetrating the lipid
membrane of the skin. The wa-
ter molecules and the ions, fill-
ing the empty spaces between
lipidic layers, are not showed for
clarity. In the pictures A2 and B2
the lipidsweremade transparent
to allow the observation of the
fullerene inside the membrane.
A – Simulation with 10 fullerene
molecules. A1 – Starting point.
A2 – after 1 μs of simulation.
B – Simulation with 30 fullerene
molecules. B1 – Starting point.
B2 – after 1 μs of simulation.
this behavior. As previously observed the opening of the lipid
membrane has an activation barrier [54] and the fullerenes are
stabilized (have negative-free energy) in the apolar, lipid tails,
regions.
The membrane model is a small one, with only four lipid bi-
layers, yet the energetics of a C60 molecule on the four bilayers are
different and cannot be extrapolated from single bilayer models.
In fact, the computed energetics indicate that the penetration of
the fullerene into the deeper layers of the skin is a favorable pro-
cess, as thepotential of themean force value for the secondbilayer
is almost the double of the value for the first bilayer. In addition,
there is a sizeable energy barrier at ζzero that could be an indica-
tion that it is energetically difficult to cross the inner water layers
inside the skin, but that value could be a consequence of the sym-
metryof themodel.Note also, that this is a highly idealizedmodel
and the lipid organizations in the skinmay not be as straight as in
the simulations allowing for permeation routes that avoid water
layers.
4 Concluding remarks
The application of fullerene C60 for transdermal delivery was
assessed and validated through in vitro tests using pig skin as a
model. Fullerene C60 was found to be able to cross the intact skin
after its dispersion in a solution of fatty acids (IPM with 20%
TRC). To ensure the validation and the relevance of the obtained
fullerene C60 permeation, the integrity of the skin was main-
tained throughout all experiments. The successful permeation
of fullereneC60 into the dermis layerwas supported bymolecular
dynamics simulations. These results reveal that a simple formu-
lation using fatty acids can deliver fullerene C60 transdermally.
Fromhere the use of fullerene C60 could be expanded in an easier
and greener implementation for the cosmetics/pharmaceutical
use. Skin aging and health in general could be improved by the
inherent benefits of the antioxidant properties of the fullerene
C60. As far as we know there is no cosmetic/pharmaceutical for-
mulation available using fullerene C60 in isopropyl myristate
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Figure 5. Snapshots of the
pulling simulation. The lipids are
represented transparent to allow
the observation of the fullerene
molecule.
Figure 6. (A) Potential of mean force calculated
across the trajectory of the pulling simulation. ζ
represents the reaction coordinate defined as the
distance between the fullerene molecule center
of mass and the middle plane of the membrane.
(B) Representation of the membrane model. The
membrane is represented on the graph scale for
the direct visualization of the reaction coordinate
showing that the energy minima are located in the
interior of the bilayers.
and/or transcutol. These dispersions make fullerene C60 suitable
to be delivered transdermally by direct application in the skin
without harsh organic solvents or any chemical modification or
encapsulation process.
The benefits of antioxidants have been extensively investi-
gated, particularly in general heath (e.g. extending the lifespan)
or in skin aging (delaying the normal aging process).
This study was supported by the Portuguese Foundation for Sci-
ence and Technology (FCT) under the scope of the strategic fund-
ing of UID/BIO/04469/2013 unit and COMPETE 2020 (POCI-
01-0145-FEDER-006684).). Artur Ribeiro thanks FCT for the
SFRH\BPD\98388\2013 grant.
The authors have declared no conflict of interest.
736 C© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.els-journal.com Eng. Life Sci. 2017, 17, 732–738
5 References
[1] Kroto, H. W., Heath, J. R., O’Brien, S. C., Curl, R. F. et al., C60:
Buckminsterfullerene. Nature 1985, 318, 162–163.
[2] Zhou, Z, Liposome formulation of fullerene-based molecular
diagnostic and therapeutic agents. Pharmaceutics 2013, 5, 525–
541.
[3] Krusic, P. J., Wasserman, E., Keizer, P. N., Morton, J. R. et al.,
Radical reactions of C60. Sciences 1991, 254, 1183–1185.
[4] Wang, I. C., Tai, L. A., Lee, D. D., Kanakamma, P. P. et al., C60
and water-soluble fullerene derivatives as antioxidants against
radical-initiated lipid peroxidation. J. Med. Chem. 1999, 42,
4614–4620.
[5] Anilkumar, P., Lu, F., Cao, L., Luo, P. G. et al., Fullerenes for
applications in biology and medicine. Curr. Med. Chem. 2011,
18, 2045–2059.
[6] Bosi, S., Da Ros, T., Spalluto, G., Prato, M., Fullerene deriva-
tives: An attractive tool for biological applications. Eur. J. Med.
Chem. 2003, 38, 913–923.
[7] Lobo, V., Patil, A., Phatak, A., Chandra, N., Free radicals, an-
tioxidants and functional foods: Impact on human health.
Pharmacognosy Rev. 2010, 4, 118–126.
[8] Nimse, S. B., Pal, D., Free radicals, natural antioxidants, and
their reaction mechanisms. RSC Adv. 2015, 5, 27986–28006.
[9] Dellinger, A., Zhou, Z., Connor, J., Madhankumar, A. B.
et al., Application of fullerenes in nanomedicine: An update.
Nanomedicine 2013, 8, 1191–1208.
[10] Daroczi, B., Kari, G., McAleer, M. F., Wolf, J. C. et al., In
vivo radioprotection by the fullerene nanoparticle DF-1 as as-
sessed in a zebrafish model. Clin. Cancer. Res. 2006, 12, 7086–
7091.
[11] Ngan, C. L., Basri, M., Tripathy, M., Abedi Karjiban, R. et al.,
Skin intervention of fullerene-integrated nanoemulsion in
structural and collagen regeneration against skin aging. Eur.
J. Pharm. Sci. 2015, 70, 22–28.
[12] Dugan, L. L., Turetsky, D. M., Du, C., Lobner, D. et al., Car-
boxyfullerenes as neuroprotective agents. Proc. Natl. Acad. Sci.
USA 1997, 94, 9434–9439.
[13] Basso, A. S., Frenkel, D., Quintana, F. J., Costa-Pinto, F. A.
et al., Reversal of axonal loss and disability in a mouse model
of progressivemultiple sclerosis. J. Clin. Invest.2008,118, 1532–
1543.
[14] Gonzalez, K. A.,Wilson, L. J.,Wu,W.,Nancollas, G.H., Synthe-
sis and in vitro characterization of a tissue-selective fullerene:
Vectoring C60(OH)16AMBP to mineralized bone. Biorg. Med.
Chem. 2002, 10, 1991–1997.
[15] Dellinger, A., Zhou, Z., Lenk, R., MacFarland, D. et al.,
Fullerene nanomaterials inhibit phorbol myristate acetate-
induced inflammation. Exp. Dermatol. 2009, 18, 1079–1081.
[16] Catala´n, J., Saiz, J. L., Laynez, J. L., Jagerovic,N. et al., The colors
of C60 solutions. Angewandte Chemie International Edition in
English 1995, 34, 105–107.
[17] Ruoff, R. S., Tse, D. S., Malhotra, R., Lorents, D. C., Solubility
of fullerene (C60) in a variety of solvents. J. Phys. Chem. 1993,
97, 3379–3383.
[18] Makitra, R. G., Pristanskii, R. E., Flyunt, R. I., Solvent Effects
on the Solubility of C60 fullerene. Russ. J. Gen. Chem. 2003, 73,
1227-1232.
[19] Kiss, I. Z., Ma´ndi, G., Beck, M. T., Artificial neural network
approach to predict the solubility of C60 in various solvents. J.
Phys. Chem. A 2000, 104, 8081–8088.
[20] Sayes, C. M., Gobin, A. M., Ausman, K. D., Mendez, J. et al.,
Nano-C60 cytotoxicity is due to lipid peroxidation. Biomateri-
als 2005, 26, 7587–7595.
[21] Aschberger, K., Johnston, H. J., Stone, V., Aitken, R. J. et al., Re-
view of fullerene toxicity and exposure—appraisal of a human
health risk assessment, based on open literature. Reg. Toxicol.
Pharmacol. 2010, 58, 455–473.
[22] Cataldo, F., Encapsulation of C60 fullerene in γ-cyclodextrin:
A new concept in the protection of organic substrates and
polymers from ozone attack: Kinetic aspects on the reactivity
between C60 and O3. Polym. Degradation Stab. 2002, 77, 111–
120.
[23] Benn, T. M., Westerhoff, P., Herckes, P., Detection of fullerenes
(C60 and C70) in commercial cosmetics. Environ. Pollut. 2011,
159, 1334–1342.
[24] Braun, T., Ma´rk, L., Ohmacht, R., Sharma, U., Olive oil as a
biocompatible solvent for pristine C60. Fullerenes Nanotubes
Carbon Nanostruct. 2007, 15, 311–314.
[25] Cataldo, F., Braun, T., The solubility of C60 fullerene in long
chain fatty acids esters. Fullerenes Nanotubes Carbon Nanos-
truct. 2007, 15, 331–339.
[26] Cataldo, F., Solubility of fullerenes in fatty acids esters: A new
way to deliver in vivo fullerenes. Theoretical calculations and
experimental results. In: Cataldo, F., Da Ros, T. (Eds.), Medic-
inal Chemistry and Pharmacological Potential of Fullerenes and
Carbon Nanotubes. Springer Netherlands, Dordrecht 2008, pp.
317–335.
[27] Hess, B., Kutzner, C., van der Spoel, D., Lindahl, E. GROMACS
4: Algorithms for highly efficient, load-balanced, and scalable
molecular simulation. J. Chem. Theory Comput. 2008, 4, 435–
447.
[28] Marrink, S. J., Risselada, H. J., Yefimov, S., Tieleman, D. P.
et al., The MARTINI force field: Coarse grained model for
biomolecular simulations. J. Phys. Chem. B 2007, 111, 7812–
7824.
[29] Hess, B., Bekker, H., Berendsen, H. J. C., Fraaije, J. G. E. M.,
LINCS: A linear constraint solver for molecular simulations. J.
Comput. Chem. 1997, 18, 1463–1472.
[30] Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F.,
DiNola, A. et al., Molecular dynamics with coupling to an
external bath. J. Chem. Phys. 1984, 81, 3684.
[31] Martins, M., Azoia, N. G., Ribeiro, A., Shimanovich, U. et al.,
In vitro and computational studies of transdermal perfusion of
nanoformulations containing a largemolecularweight protein.
Colloids Surfaces B 2013, 108, 271–278.
[32] Torres, V. M., Posa, M., Srdjenovic, B., Simplı´cio, A. L., Sol-
ubilization of fullerene C60 in micellar solutions of different
solubilizers. Colloids Surfaces B 2011, 82, 46–53.
[33] He, C.-L., Liu, R., Li, D.-D., Zhu, S.-E. et al., Synthesis and
functionalization of [60] fullerene-fused imidazolines.Organic
Lett. 2013, 15, 1532–1535.
[34] Afreen, S., Muthoosamy, K., Manickam, S., Hashim, U., Func-
tionalized fullerene (C60) as a potential nanomediator in the
fabrication of highly sensitive biosensors. Biosensors Bioelec-
tronics 2015, 63, 354–364.
C© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 737
www.els-journal.com Eng. Life Sci. 2017, 17, 732–738
[35] Gao, J., Wang, H. L., Shreve, A., Iyer, R. Fullerene derivatives
inducepremature senescence:Anew toxicityparadigmornovel
biomedical applications. Toxicol. Appl. Pharmacol. 2010, 244,
130–143.
[36] Partha, R., Conyers, J. L., Biomedical applications of function-
alized fullerene-based nanomaterials. Int. J. Nanomed. 2009, 4,
261–275.
[37] Benn, T. M., Westerhoff, P., Herckes, P., Detection of fullerenes
(C(60) and C(70)) in commercial cosmetics. Environ. Poll.
2011, 159, 1334–1342.
[38] Marcus, Y., Smith, A. L., Korobov, M. V., Mirakyan, A. L. et al.,
Solubility of C60 fullerene. J. Phys. Chem. B 2001, 105, 2499–
2506.
[39] Cataldo, F., Solubility of fullerenes in fatty acids esters: A new
way to deliver in vivo fullerenes. Theoretical calculations and
experimental results. In: Cataldo, F., Da Ros, T. (Eds.), Medic-
inal chemistry and pharmacological potential of fullerenes and
carbon nanotubes. Springer Netherlands, Dordrecht 2008, pp.
317–335.
[40] Sato, K., Sugibayashi, K., Morimoto, Y., Effect and mode of
action of aliphatic esters on the in vitro skin permeation of
nicorandil. Int. J. Pharm. 1988, 43, 31–40.
[41] Mura, P., Faucci, M. T., Bramanti, G., Corti, P. Evaluation of
transcutol as a clonazepam transdermal permeation enhancer
from hydrophilic gel formulations. Eur. J. Pharma. Sci. 2000,
9, 365–372.
[42] Godwin, D. A., Kim, N.-H., Felton, L. A., Influence of
Transcutol R© CG on the skin accumulation and transdermal
permeation of ultraviolet absorbers. Eur. J. Pharm. Biopharm.
2002, 53, 23–27.
[43] Marzulli, F., Maibach, H. I., Relevance of animal models: the
hexachlorophene story, In:Maibach,H. I. (Ed.),Animalmodels
in dermatology. Churchill Livingstone. Edinburgh 1975, pp.
156–167.
[44] Bronaugh, R. L., Stewart, R. F., Congdon, E. R., Meth-
ods for in vitro percutaneous absorption studies II. Animal
models for human skin. Toxicol. Appl. Pharmacol. 1982, 62,
481–488.
[45] Haigh, J. M., Smith, E.W., The selection and use of natural and
synthetic membranes for in vitro diffusion experiments. Eur.
J. Pharm. Sci. 1994, 2, 311–330.
[46] Morris, G. M., Hopewell, J. W., Epidermal cell kinetics of the
pig: A review. Cell Prolif. 1990, 23, 271–282.
[47] Sullivan, T. P., Eaglstein, W. H., Davis, S. C., Mertz, P., The pig
as a model for human wound healing. Wound Repair Regen.
2001, 9, 66–76.
[48] Harunari, N., Zhu, K. Q., Armendariz, R. T., Deubner, H.
et al., Histology of the thick scar on the female, red Duroc pig:
Final similarities to human hypertrophic scar. Burns 2006, 32,
669–677.
[49] Gallo, S. A., Sen, A., Hensen,M. L., Hui, S.W. Time-dependent
ultrastructural changes to porcine stratum corneum following
an electric pulse. BpJ. 1999, 76, 2824–2832.
[50] Holbrook, K. A., Odland, G. F., Regional differences in the
thickness (cell layers) of the human stratum corneum: An
ultrastructural analysis. J. Invest. Dermatol. 1974, 62, 415–
422.
[51] Wester, R. C., Melendres, J., Sedik, L., Maibach, H.
et al., Percutaneous absorption of salicylic acid, theo-
phylline, 2,4-dimethylamine, diethyl hexyl phthalic acid, andp-
aminobenzoic acid in the isolated perfused porcine skin flap
compared to manin vivo. Toxicol. Appl. Pharmacol. 1998, 151,
159–165.
[52] Benson, H., Transdermal drug delivery: Penetration enhance-
ment techniques. Curr. Drug Delivery 2005, 2, 23–33.
[53] Ho¨finger, S., Melle-Franco, M., Gallo, T., Cantelli, A. et al., A
computational analysis of the insertion of carbon nanotubes
into cellular membranes. Biomaterials 2011, 32, 7079–7085.
[54] Bedrov, D., Smith, G. D., Davande, H., Li, L. Passive trans-
port of C60 fullerenes through a lipid membrane: A molecular
dynamics simulation study. J. Phys. Chem. B 2008, 112, 2078–
2084.
738 C© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
